These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30581268)

  • 1. Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors.
    Li J; Wang M; Zhang B; Wu X; Lin TL; Liu XF; Zhou Y; Zhang XH; Xu H; Shen LJ; Zou J; Lu P; Zhang D; Gu WJ; Zhang MX; Pan J; Cao H;
    World J Gastroenterol; 2018 Dec; 24(46):5189-5202. PubMed ID: 30581268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors].
    Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):801-806. PubMed ID: 31550816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group.
    Sodergren SC; White A; Efficace F; Sprangers M; Fitzsimmons D; Bottomley A; Johnson CD
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):35-46. PubMed ID: 24495942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical management of tyrosine kinase inhibitor-associated side effects in GIST.
    Joensuu H; Trent JC; Reichardt P
    Cancer Treat Rev; 2011 Feb; 37(1):75-88. PubMed ID: 20570050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events associated with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.
    Breccia M; Colafigli G; Molica M; Alimena G
    Expert Opin Drug Saf; 2016; 15(4):525-33. PubMed ID: 26799331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule tyrosine kinase inhibitor and depression.
    Quek R; Morgan JA; George S; Butrynski JE; Polson K; Meyer F; Demetri GD; Block SD
    J Clin Oncol; 2009 Jan; 27(2):312-3. PubMed ID: 19064960
    [No Abstract]   [Full Text] [Related]  

  • 9. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
    Nishida T; Doi T; Naito Y
    Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regorafenib: a novel multitargeted tyrosine kinase inhibitor for colorectal cancer and gastrointestinal stromal tumors.
    Crona DJ; Keisler MD; Walko CM
    Ann Pharmacother; 2013 Dec; 47(12):1685-96. PubMed ID: 24259629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underuse of exon mutational analysis for gastrointestinal stromal tumors.
    Bartholomew AJ; Dohnalek H; Prins PA; O'Neill SC; Quadri HS; Marshall JL; Haddad NG; Al-Refaie WB
    J Surg Res; 2018 Nov; 231():43-48. PubMed ID: 30278964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumors.
    Blanke CD; Huse DM
    J Med Econ; 2010; 13(4):681-90. PubMed ID: 21067355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Gastrointestinal Stromal Tumour: Current Practices and Visions for the Future.
    Blay JY; Casali PG; Dei Tos AP; Le Cesne A; Reichardt P
    Oncology; 2015; 89(1):1-13. PubMed ID: 25720422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.
    Resteghini C; Cavalieri S; Galbiati D; Granata R; Alfieri S; Bergamini C; Bossi P; Licitra L; Locati LD
    Best Pract Res Clin Endocrinol Metab; 2017 Jun; 31(3):349-361. PubMed ID: 28911730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents.
    Betz M; Kopp HG; Spira D; Claussen CD; Horger M
    Acta Radiol; 2013 Sep; 54(7):711-21. PubMed ID: 23761542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current research and treatment for gastrointestinal stromal tumors.
    Lim KT; Tan KY
    World J Gastroenterol; 2017 Jul; 23(27):4856-4866. PubMed ID: 28785140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of tyrosine kinase inhibitors used for gastrointestinal stromal tumors.
    Chintalgattu V; Patel SS; Khakoo AY
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):97-107, viii-ix. PubMed ID: 19248973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.
    Raut CP; Posner M; Desai J; Morgan JA; George S; Zahrieh D; Fletcher CD; Demetri GD; Bertagnolli MM
    J Clin Oncol; 2006 May; 24(15):2325-31. PubMed ID: 16710031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient.
    Demirci U; Coskun U; Erdem O; Ozturk B; Bilge Yilmaz I; Benekli M; Buyukberber S
    J Oncol Pharm Pract; 2011 Sep; 17(3):285-7. PubMed ID: 20551113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear].
    Ahlman H; Nilsson O; Nilsson B
    Lakartidningen; 2009 Dec 9-21; 106(50-51):3424-9. PubMed ID: 20180446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.